Search for Clinical Trial Results
Carcinoma, Adenoid Cystic - 25 Studies Found
Status | Study |
Completed |
Study Name: Compassionate Use of Brontictuzumab for Adenoid Cystic Carcinoma (ACC) Condition: Adenoid Cystic Carcinoma Date: 2016-01-22 Interventions: Drug: Brontictuzumab 1.5 mg/Kg intravenously every three weeks. |
Active, not recruiting |
Study Name: Regorafenib in Patients With Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma Condition: Adenoid Cystic Carcinoma Date: 2014-03-24 Interventions: Drug: Regorafenib All eligible patients will receive a starting regorafenib dose of 120 mg daily taken o |
Completed |
Study Name: Axitinib (AG-013736) in Patients With Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma Condition: Adenoid Cystic Carcinoma Date: 2012-03-16 Interventions: Drug: AG-013736 (AXITINIB) All eligible patients will receive a starting axitinib dose of 5 mg twice dai |
Recruiting |
Study Name: A Study of Apatinib in Metastatic Adenoid Cystic Carcinoma of the Head and Neck Condition: Adenoid Cystic Carcinoma Date: 2016-05-12 Interventions: Drug: Apatinib Mesylate Apatinib Mesylate will be administered orally at 500 mg once daily for 5 consecu |
Not yet recruiting |
Study Name: Trail Evaluating Particle Therapy With or Without Apatinib for H&N Adenoid Cystic Carcinoma Condition: Adenoid Cystic Carcinoma Date: 2016-10-18 Interventions:
|
Active, not recruiting |
Study Name: Lenvatinib in Recurrent and/or Metastatic Adenoid Cystic Carcinomas of the Salivary Glands: ACC-LEN14 Condition: Adenoid Cystic Carcinomas of the Salivary Glands Date: 2016-08-02 Interventions: Drug: Lenvatinib Lenvatinib will be self orally administered at 24 mg daily, on a continuous basis in 4 |
Completed |
Study Name: A Study of Sunitinib in Recurrent and/or Metastatic Adenoid Cystic Carcinoma of the Salivary Glands Condition:
Date: 2009-04-20 Interventions: Drug: Sunitinib 37.5 mg taken orally, daily every 28-day cycles |
Completed |
Study Name: A Phase II Study of Dovitinib in Recurrent and/or Metastatic Adenoid Cystic Carcinoma of the Salivary Glands Condition:
|
Recruiting |
Study Name: Study of Axitinib in Patients With Recurred or Metastatic Adenoid Cystic Carcinoma Condition: Recurrent ACC, metastaticACC, Unreaectable ACC Date: 2016-07-28 Interventions:
|
Completed |
Study Name: Gemcitabine in Treating Patients With Recurrent or Metastatic Adenoid Cystic Cancer of the Head and Neck Condition: Head and Neck Cancer Date: 2001-06-06 Interventions: Drug: gemcitabine hydrochloride |